Skip to main content

Jeremy Bender

CEO

Day One Biopharmaceuticals, Inc.

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jeremy Bender

Jeremy Bender is recorded as CEO at Day One Biopharmaceuticals, Inc.. Day One Biopharmaceuticals, Inc. reported in an 8-K filed April 23, 2026 that Jeremy Bender resigned as director, effective April 23, 2026. The proxy statement of Day One Biopharmaceuticals, Inc. reports total compensation of $6,560,577 for Jeremy Bender in fiscal 2024, including a base salary of $680,000. Disclosed compensation is on record for 5 fiscal years. Jeremy Bender has spoken on 6 earnings calls across 1 company, most recently for Day One Biopharmaceuticals, Inc. on February 24, 2026.

“As of the Effective Time, Jeremy Bender, Habib Dable, Scott Garland, William Grossman, Natalie Holles, John Josey, Garry Nicholson and Saira Ramasastry each ceased to be directors of the Company and members of any committee of the Company's board of directors.”
Day One Biopharmaceuticals, Inc. Form 8-K, filed April 23, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • Day One Biopharmaceuticals, Inc.

    CEO

    Proxy statement

    Current

    Start not stated–present

  • Day One Biopharmaceuticals, Inc.

    Board Member

    Proxy statement

    2020-01-01–2026-04-23

Company network

Recorded roles and call appearances connecting this person to public companies.

Day One Biopharmaceuticals, Inc.

Current role

CEO

2020-01-01–present

6 appearances Latest appearance 2026-02-24

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Day One Biopharmaceuticals, Inc. $680,000 $6,560,577
2023 Day One Biopharmaceuticals, Inc. $647,000 $6,913,959
2022 Day One Biopharmaceuticals, Inc. $610,000 $5,086,456
2021 Day One Biopharmaceuticals, Inc. $523,021 $19,761,110
2020 Day One Biopharmaceuticals, Inc. $141,667 $2,753,181

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

  • Executive change Resigned: director

    Day One Biopharmaceuticals, Inc.

  • Earnings call

    Day One Biopharmaceuticals, Inc. Q4 FY2025 Earnings Call

    Day One Biopharmaceuticals, Inc.

  • Earnings call

    Day One Biopharmaceuticals, Inc. Q3 FY2025 Earnings Call

    Day One Biopharmaceuticals, Inc.

  • Earnings call

    Day One Biopharmaceuticals, Inc. Q2 FY2025 Earnings Call

    Day One Biopharmaceuticals, Inc.

  • Earnings call

    Day One Biopharmaceuticals, Inc. Q1 FY2025 Earnings Call

    Day One Biopharmaceuticals, Inc.

  • Earnings call

    Day One Biopharmaceuticals, Inc. Q4 FY2024 Earnings Call

    Day One Biopharmaceuticals, Inc.

  • Earnings call

    Day One Biopharmaceuticals, Inc. Q3 FY2024 Earnings Call

    Day One Biopharmaceuticals, Inc.